68Ga-PSMA-11 PET/CT derived quantitative volumetric tumor parameters for classification and evaluation of therapeutic response of bone metastases in prostate cancer patients.
Aged
Aged, 80 and over
Bone Neoplasms
/ diagnostic imaging
Edetic Acid
/ analogs & derivatives
Gallium Isotopes
Gallium Radioisotopes
Humans
Male
Middle Aged
Neoplasm Grading
Oligopeptides
Positron Emission Tomography Computed Tomography
Prostatic Neoplasms
/ metabolism
Recurrence
Time Factors
Treatment Outcome
68Ga-PSMA-11 PET/CT
Bone metastases
Quantitative tumor parameters
Treatment response
Journal
Annals of nuclear medicine
ISSN: 1864-6433
Titre abrégé: Ann Nucl Med
Pays: Japan
ID NLM: 8913398
Informations de publication
Date de publication:
Oct 2019
Oct 2019
Historique:
received:
07
06
2019
accepted:
16
07
2019
pubmed:
25
7
2019
medline:
11
2
2020
entrez:
25
7
2019
Statut:
ppublish
Résumé
To evaluate the role of A total of 177 men with biochemical recurrence of prostate cancer suffering from bone metastases underwent PET/CT with [ In 177 patients, a total of 443 Our results suggest that
Sections du résumé
BACKGROUND
BACKGROUND
To evaluate the role of
METHODS
METHODS
A total of 177 men with biochemical recurrence of prostate cancer suffering from bone metastases underwent PET/CT with [
RESULTS
RESULTS
In 177 patients, a total of 443
CONCLUSION
CONCLUSIONS
Our results suggest that
Identifiants
pubmed: 31338731
doi: 10.1007/s12149-019-01387-0
pii: 10.1007/s12149-019-01387-0
doi:
Substances chimiques
Gallium Isotopes
0
Gallium Radioisotopes
0
Oligopeptides
0
gallium 68 PSMA-11
0
Edetic Acid
9G34HU7RV0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM